Maternal Serum Periostin as a Potential Biomarker for Gestational Diabetes Mellitus and Adverse Perinatal Outcomes
Zeitschrift für Geburtshilfe und Neonatologie · 01.10.2026 · 230 (05) · 419-424
DOI: 10.1055/a-2827-9333 ↗Kurz gefasst
Fachartikel in der Zeitschrift Zeitschrift für Geburtshilfe und Neonatologie, erschienen am 01.10.2026. Verfasst von Semra Eroglu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Obstetric and Gynecology, Samsun University Faculty of Medicine, Canik, Turkey. Hauptthemen laut MEDLINE: Diabetes, Gestational, Periostin, Pregnancy Outcome, Cell Adhesion Molecules. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
To investigate whether maternal serum periostin levels measured in the second trimester can serve as a biomarker for gestational diabetes mellitus (GDM) and predict perinatal outcomes. This prospective case–control study included 173 pregnant women (103 with GDM and 70 healthy controls). Serum periostin levels were measured between 15–20 weeks of gestation. GDM was diagnosed using a 75-g oral glucose tolerance test at 24–28 weeks. Receiver operating characteristic (ROC) analysis and logistic regression were used to evaluate diagnostic performance. Serum periostin levels were significantly higher in the GDM group compared to controls (median: 50.7 vs. 33.7 ng/mL, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Obstetric and Gynecology, Samsun University Faculty of Medicine, Canik, Turkey.
- Obstetrics and Gynecology, Istanbul Aydin University, Istanbul, Turkey.
- Biochemistry, Ondokuz Mayis University, Samsun, Turkey.
- Biochemistry, Ministry of Health Samsun Education and Research Hospital, Ilkadim, Turkey.
- Health Science, Samsun Provincial Health Directorate, İlkadım, Turkey.
ORCID-Profile: Yeşim Civil Ürkmez
Zitieren
APA
Eroglu, S., Gumusburun, N., Urkmez, S. S., Civil Ürkmez, Y., Çelik, S., & Şahin, K. (2026). Maternal Serum Periostin as a Potential Biomarker for Gestational Diabetes Mellitus and Adverse Perinatal Outcomes. Zeitschrift für Geburtshilfe und Neonatologie, 230(05), 419-424. https://doi.org/10.1055/a-2827-9333
Vancouver
Eroglu S, Gumusburun N, Urkmez SS, Civil Ürkmez Y, Çelik S, Şahin K. Maternal Serum Periostin as a Potential Biomarker for Gestational Diabetes Mellitus and Adverse Perinatal Outcomes. Zeitschrift für Geburtshilfe und Neonatologie. 2026;230(05):419-424. doi:10.1055/a-2827-9333
BibTeX
@article{Eroglu2026,
author = {Eroglu, Semra and Gumusburun, Neset and Urkmez, Sebati Sinan and Civil Ürkmez, Yeşim and Çelik, Samettin and Şahin, Kübra},
title = {Maternal Serum Periostin as a Potential Biomarker for Gestational Diabetes Mellitus and Adverse Perinatal Outcomes},
journal = {Zeitschrift für Geburtshilfe und Neonatologie},
year = {2026},
volume = {230},
number = {05},
pages = {419--424},
doi = {10.1055/a-2827-9333}
}
EUVIMED